Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Cevimeline hydrochloride hemihydrate

Cevimeline hydrochloride hemihydrate

pharmaceutical raw materials
Cevimeline hydrochloride hemihydrate structure

Cevimeline hydrochloride hemihydrate 

structure

Description

Cevimeline hydrochloride hemihydrate, a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome. IC50 value:Target: mAChRThe general pharmacol. properties of this drug on the gastrointestinal, urinary, and reproductive systems and other tissues were investigated in mice, rats, guinea pigs, rabbits, and dogs. The in vitro metab. of SNI-2011 was also evaluated with rat and dog liver microsomes. After oral administration, plasma concns. of SNI

Cevimeline hydrochloride hemihydrate Basic Attributes

435.09

488.170091

DTXSID9022788

Characteristics

84.77000

4.53590

1.19g/cm3

308.5ºC at 760mmHg

140.4ºC

Safety Information

UN 2811 6.1 / PGIII

P301 + P310

H301

|Danger|H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]|P201, P202, P261, P264, P270, P271, P281, P301+P310, P304+P312, P304+P340, P308+P313, P312, P321, P330, P405, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Computed Properties

Molecular Weight:489.6
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:7
Exact Mass:488.1700908
Monoisotopic Mass:488.1700908
Topological Polar Surface Area:76.5
Heavy Atom Count:29
Complexity:215
Defined Atom Stereocenter Count:4
Covalently-Bonded Unit Count:5
Compound Is Canonicalized:Yes

Recommended Suppliers of Cevimeline hydrochloride hemihydrate

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.